Investors have been listening to & looking for "buyout" since BEFORE the nineteenth century. What you can look for is, lower stock price if you still want the shares, more dilution from an upcoming "private placement", & an out of court settlement on the pending lawsuit.
FDA approval? You're right, it's a "few" years away; definition of a "few" is 2 years to never.
Question is..... .....will GALT find support at $2.50 or $2.00 AFTER the LOSS statement is released. The stock market in in the midst of it's traditional "summer doldrums". Your guess is as good as anyones.
I did an internet search for Adam Allgood. I just don't see that he brings anything significant to GALT except an added expense.
GALT financials will probably be released AFTER the close of business on Friday 31 July & hope you'll not notice the news during the weekend. Of course the report won't reveal the increase in overhead by the hiring of ALLGOOD for another 3 months
I'd like to suggest you copy & paste the Names & number of shares held by Institutions now, then look & compare AFTER the new financials are released.
It should be instructive/interesting see IF there is an increase or decrease in the number of institutions holding shares....& interesting to see IF they's increased or decreased their holding in GALT.
Incidentally, Darla, I'm quite skeptical of GALT & Mr Czirr after the lawsuit was filed & am going to wait until it is settled before I make a decision to take money out of my pocket for more stock. I only own 1,000 shares. Once the lawsuit is settled one way or another, then & only then will I consider buying more shares at any price.
just IGNORE jsm190070, add him to your IGNORE list. He's not said anything that has any value or knowledge to anyone
Darla, If the opportunity presents itself, please see if you can re-establish some dialog with those doctors you've spoken to in the past. 3 years is a long time & it's possible they may not have the same favorable viewpoint.
Darla73399, do you KNOW if the physicians in Indiana who thought GALT was onto something in 2012, STILL think GALT is onto something? I think we'd all be interested to KNOW "their" PRESENT thinking/belief/opinion
I'm thinking the ONLY way for GALT to get out from under the lawsuit, is to declare BANKRUPTCY.
IF GALT does a secondary offering they are only sweetening the pot for the litigants in the law suit to go after. And I seriously doubt under the circumstances GALT will be able to entice/lure any additional Private Placement suckers.
You've also got ask yourself WHY some of the Doctors that are going to be involved with the P2 tests 'come out publicly stating that they are stockholders, however there might be a question of "Conflict of Interest".
You've also gotta ask yourself WHY Institutional Investors keep reducing their stake in the company.
Dr Traber is THE person, the most valuable asset amongst the GALT management; I have a hard time believing Dr Traber knew anything about the events leading up to the lawsuit. Frankly, I'm surprised he's not resigned out of disgust on account of the events leading up to the lawsuit -- all of the foregoing is merely, my opinion.
This time TWO years ago the stock was selling in the $1.25 range; However, since June 2014, more than a year the stock has essentially moved sideways; that's called treading water. And as of today, the treatment still hasn't been tested on humans.
I rather suspect those that bought in at $1.25 , TWO YEARS AGO, will take issue with your claim that this is the Cheapest Medical Device Stock I've ever seen.
hmmmm, looks like your RIGHT, spike is DOWN, into the ground.
got anymore prognostications as to a good low $2.00+ "accumulate now"?
Get READY, for WHAT, warrenbuffet: for the price to trend sideways, for it to drop due to disappointing test results, or spike up on news deemed FAVORABLE by investors?
Just for the Record, I've been under the impression Q2 results will be released AFTER Q2 ends, mean sometime in early July; looking at July Calendar & considering Saturday, 4th of July & that many people will be taking a long weekend beginning Friday...my own best GUESS is the test results will be announced AFTER the long 4th of July weekend.
Friday, 19 June 2015; NO SHARES traded today....nada, zip, zilch
Hard to believe no one could get together to trade a single share. Makes me wonder why this stock is even listed.
I seriously doubt there will be a Secondary until the lawsuit is settled one way or the other. With the lawsuit hanging over their head, GALT isn't likely to add more money to their kitty that could be in danger of the lawsuit settlement.
Czirr, not Traber is the person that will make the decision on IF or WHEN or at WHAT PRICE to do a Secondary.
You're right about the Secondary price, it definitely going to be priced a good 30%-40% less than the prevailing stock share price.....so you have to ask yourself, WHY buy any shares now, better to sit on the sidelines & wait for the lawsuit to settle & wait until AFTER the Secondary, in my opinion
Does this mean dbturn will be making his normal 14,000+ posts every year from now on, on HL's board?
Here is what Patrick Cox had to say about GALT in a March 24 2015 article:
PATRICK COX IS TELLING OTHER NOT TO BUY GALT. Patrick may be friends with Mauldin, but that hasn't influenced him to say favorable things about GALT, to the contrary.
Pretty as a peach, Georgian outfit Galectin Therapeutics ($GALT), a $90M NASDAQ-listed company, putzes along with its plan to take proletarian citrus pectin (i.e, orange peel), college educate it, send it to a finishing school in Switzerland, and make a NASH drug out of it. There’s just one small problem and it’s a large one: it takes pages and pages of handwringing and intellectual self-stimulation to rationalize even a remote chance that this agent might help with NASH. It does not address lipid metabolism, fat burning, fat export or mitochondrial performance. Pectin does nothing to or for liver. Above all else, the one sure thing is that it does not address insulin resistance! Pull up a one-year chart on $GALT and you’ll see one of the ugliest traces in biotech. Imagine Cramer: “Don’t buy! Don’t buy! Don’t buy!‘
I'm one that rated your reply with a "thumbs down". Patrick Cox doesn't "work for" John Mauldin or anyone other than for himself……unless & until you can show me such DOCUMENTATION.